Welcome to our dedicated page for Greenlight Capital Re SEC filings (Ticker: GLRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Greenlight Capital Re filings document a Cayman Islands holding company with multiline property and casualty insurance and reinsurance operations. Form 8-K reports cover quarterly and annual operating results, underwriting measures, investment income, book value per share and ordinary-share repurchase activity.
The company’s regulatory filings also disclose material financing arrangements, including revolving credit and letter-of-credit facilities involving its reinsurance subsidiaries. Proxy materials cover board matters, executive compensation, equity awards and shareholder voting, while other 8-K filings record leadership and corporate-governance events.
Greenlight Capital Re, Ltd. controller Sherry Diaz reported selling 987 ordinary shares of the company in an open-market transaction. The sale left her with 96,571 shares of Greenlight Capital Re stock, indicating she continues to hold a substantial position after this relatively small disposition.
GREENLIGHT CAPITAL RE, LTD. reported that Chief Financial Officer Faramarz Romer disposed of 2,689 ordinary shares on March 9, 2026. A footnote explains these were performance-based restricted shares granted in 2023 that were forfeited rather than sold for cash. Following this non-derivative disposition, Romer directly holds 152,481 ordinary shares, indicating he maintains a substantially larger remaining equity stake in the company.
CURNOCK THOMAS JAMES reported open-market sale transactions in this Form 4 filing.
GREENLIGHT CAPITAL RE, LTD. executive Thomas James Curnock, the Group Chief Underwriting Officer, reported a disposition of 6,552 ordinary shares on March 9, 2026. A footnote explains these shares were forfeited performance-based restricted stock granted in 2023. After this event, he directly holds 163,338 ordinary shares.
GREENLIGHT CAPITAL RE, LTD. executive Brian Joseph O’Reilly, Head of Innovations, recorded a disposition of 2,195 ordinary shares on March 9, 2026. A footnote clarifies these shares were forfeited performance-based restricted stock granted in 2023, rather than a discretionary market sale. Following the forfeiture, O’Reilly directly holds 97,135 ordinary shares, indicating this was a relatively small adjustment to his overall equity position.
GREENLIGHT CAPITAL RE, LTD. Chief Actuary Richard Paul Strommer reported a disposition of 2,786 ordinary shares on March 9, 2026. A footnote explains these shares were forfeited performance-based restricted stock granted in 2023, rather than an open-market sale for cash. Following this forfeiture, Strommer directly holds 68,025 ordinary shares, indicating a relatively small reduction in his equity position.
GREENLIGHT CAPITAL RE, LTD. Chief Operating Officer Patrick O'Brien acquired 31,961 ordinary shares on March 9, 2026 through the vesting of restricted stock units that converted into shares. The shares were granted at no cash cost to him and are held directly. Following this award, he owns a total of 202,386 ordinary shares.
Greenlight Capital Re is a Cayman Islands–based specialty property and casualty reinsurer operating through its Open Market and Innovations segments and a Lloyd’s platform. The company focuses on multi-line P&C reinsurance, insurtech partnerships, and a value-oriented investment strategy.
In 2025, consolidated gross premiums written rose 10.7% to $773.3 million, led by the Open Market segment and a 28% increase in Innovations premiums to $121.6 million. At December 31, 2025, the company reported $2.2 billion in total assets, $0.7 billion in shareholders’ equity, and a 13.8% increase in fully diluted book value per share.
Management highlights strong operating cash flows that supported share repurchases and repayment of most outstanding debt, alongside a disciplined focus on short- and medium-tail risks and tight underwriting controls. Investments of $633.1 million are primarily managed through the Solasglas fund, which returned 7.5% in 2025. A.M. Best upgraded the group’s Financial Strength Rating to A (Excellent) with a stable outlook, reflecting perceived improvements in balance sheet strength and operating performance.
Greenlight Capital Re reported a sharp turnaround in profitability for Q4 and full-year 2025, driven by stronger underwriting and solid investment returns. In Q4 2025, gross premiums written rose 12% to $161.3 million, net underwriting swung to a $13.0 million profit from an $18.0 million loss, and the combined ratio improved to 92.1% from 112.1%. Total investment income increased to $44.8 million, supporting net income of $49.3 million, or $1.44 per diluted share, versus a loss a year earlier.
For 2025, gross premiums written grew 11% to $773.3 million, with net underwriting income of $35.7 million versus an $8.2 million loss in 2024 and a full-year combined ratio of 94.6%, better than 101.4%. Net income rose to $74.8 million ($2.17 diluted EPS). Fully diluted book value per share increased 13.8% to $20.43, helped by share repurchases of $9.8 million in 2025 and positive returns from the Solasglas investment portfolio.
Greenlight Capital Re, Ltd. reported that David Sigmon has notified the company of his intent to resign as General Counsel, Chief Compliance Officer and Corporate Secretary, effective May 1, 2026. The company states that his resignation is not due to any disagreement with management, the board, or the company’s operations, policies, or practices. Mr. Sigmon will continue in all current roles until his departure to support an orderly transition.
Greenlight Capital Re, Ltd. (GLRE) director reported an open-market purchase of company shares. On 11/20/2025, the reporting person bought 5,000 ordinary shares of GLRE at a weighted average price of $12.9182 per share. After this transaction, the director beneficially owns 54,100 ordinary shares, held directly. The filing notes that the purchase price reflects multiple trades within a range from $12.8500 to $12.9188 per share and that detailed trade-level pricing information is available upon request.